Heating Up | GenomeWeb

Heating Up

The Boston Globe notes a recent spike in biotech merger and acquisitions. The deals going through at Inverness, Biogen, and Takeda follow an 18-month-long lull. "When you've had a cycle of fear and now we're seeing real signs that growth is coming," says Kevin Gorman from Putnam Associates, "if you can pick up an asset that fits your strategy, and you can pick it up at a decent price, why not?"

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.

Arizona is planning to sue Theranos for "deceptive acts" and misrepresentations of its "capabilities and operation."

If confirmed as Department of Health and Human Services Secretary, Tom Price says he will divest himself of certain holdings, according to Stat News.

Oliver Smithies, who won the Nobel Prize in 2007, has died, the New York Times reports.